Curam FC tab/oral susp: Hypersensitivity to the active substances, to any of the penicillins or to any of the excipients.
History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam).
History of jaundice/hepatic impairment due to amoxicillin/clavulanic acid (see Adverse Reactions).
Curam Solutab: Curam Solutab is contraindicated in patients with a previous history of hypersensitivity to amoxicillin, clavulanic acid or any of the excipients.
Curam Solutab must not be administered to patients with verified hypersensitivity to any beta-lactam drug (e.g. penicillins, cephalosporin, carbapenem, monobactam) owing to the danger of anaphylactic shock. Consequently, a careful history should be taken in regard to any allergic reactions before commencing treatment.
Curam Solutab must not be used in patients with high-grade hepatic functional impairment and in patients in whom hepatic functional impairment has occurred during previous treatment with Curam Solutab, for example cholestatic jaundice induced by Curam Solutab or penicillin.
Patients with infectious mononucleosis (glandular fever) and patients with lymphatic Leukemia have a higher risk of exanthema and consequently Curam Solutab should not be administered during these diseases to treat concomitant bacterial infections.